AllazoHealth isn't building another patient app—it's building the intelligence layer that makes specialty pharmaceutical access actually work. With just 24 employees and $2.4M in revenue, this analytics firm is tackling the $300B annual cost of medication non-adherence through predictive modeling that pharmaceutical companies desperately need but rarely find.

"They're not competing with pharma giants—they're becoming the invisible infrastructure powering their patient access strategies."

The company's tech stack reveals a pragmatic approach: jQuery and Bootstrap for rapid development, Tailwind CSS for modern UI, and Google Analytics for measuring what actually matters. They're not chasing bleeding-edge tech—they're building reliable systems that pharmaceutical compliance officers can trust. The LinkedIn Insight Tag integration suggests they're targeting B2B decision-makers, not consumers.

• Predictive analytics that identify non-adherence risk before prescriptions are written
• Direct integration with specialty pharmaceutical patient support programs
• Proprietary dataset mapping medication access barriers across insurance types
• CEO William Grambley's background in healthcare analytics (not just pharma sales)
• CTO Clifford Jones building the data infrastructure that scales across drug launches